CTABF
Canntab Therapeutics Limited
Set alert
- Open
- 0.0073
- Prev close
- 0.0001
- Mkt cap
- 3.89K
- Vol
- 2.00K
- Avg vol
- 1.03K
- EPS
- -0.06
- P/E
- -0.00
More statistics
- Low
- 0.0001
- High
- 0.0073
News
2 years ago newsfilecorp.com
CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL)
Toronto, Ontario--(Newsfile Corp. - le 14 juin/June 2024) - The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024. Canntab Therapeutics…
3 years ago newsfilecorp.com
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission…
3 years ago proactiveinvestors.com
Canntab Therapeutics seeks to move manufacturing process as Markham lease expires
Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) has provided an update on several matters impacting the company, including plans to move its manufacturing operations following expiry of its lease at…
4 years ago proactiveinvestors.com
Canntab Therapeutics provides update on recent product delivery of its cannabinoid solutions to the Nova Scotia Liquor Corporation
Canntab Therapeutics Limited has provided an update on the recent product delivery of its unique pharmaceutical cannabinoid solutions to the Nova Scotia Liquor Corporation (NSLC). The company said…
4 years ago proactiveinvestors.com
Canntab Therapeutics appoints Hamish Sutherland as strategic business consultant
Canntab Therapeutics Ltd said it has appointed Hamish Sutherland as a strategic business consultant to develop additional sales and distribution channels for the company's products and to assist it…
4 years ago proactiveinvestors.com
Canntab Therapeutics inks affiliate deal with independent pharmacy owners in Ontario
Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) announced that it has entered into an affiliate agreement with OnPharm-United, a 600-plus network of independent pharmacy owners throughout the…
4 years ago proactiveinvestors.com
Canntab Therapeutics closes non-brokered private placement of secured convertible debentures for gross proceeds of $1,312,000
Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) said it has closed a non-brokered private placement of secured convertible debentures of the company, under which the company issued and will issue…
4 years ago benzinga.com
Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids
Wellness company Levitee Labs Inc. (CSE:LVT) (OTC:LVTTF) (FSE:7H7) confirmed Monday that it has teamed up with cannabinoid company Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F).…
4 years ago benzinga.com
Canntab Therapeutics Completes First Shipment Of THC Tablets To Ontario Cannabis Stores
Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F), an innovator in cannabinoid and terpene blends, said Monday that it has completed its first shipment of 5 mg THC tablets to the…
4 years ago proactiveinvestors.com
Levitee Labs partners with Canntab Therapeutics to provide alternative to drugs amid opioid crisis in Canada
Levitee Labs (CSE:LVT) Inc said it has entered into a strategic partnership via a service agreement with Canntab Therapeutics Limited to contribute towards correcting the opioid crisis in Canada.…
4 years ago proactiveinvestors.com
Canntab Therapeutics provides an update on its recent product deliveries for Ontario and Australia
Canntab Therapeutics Limited, a leading innovator in cannabinoid and terpene blends in hard pill form, provided an update on its successful product deliveries for Ontario and Australia, which augur…
4 years ago proactiveinvestors.com
Pathway Health and Canntab Therapeutics strike agreement to provide oral tablet cannabinoid products in select Canadian pharmacies
Pathway Health (TSX-V:PHC) Corp and Canntab Therapeutics Limited are teaming up to deliver Canntab's oral tablet cannabinoid products within Pathway's pharmacy network. The products will consist of a…
4 years ago proactiveinvestors.com
Canntab Therapeutics receives medical sales license from Health Canada for its Ontario facility
Canntab Therapeutics Limited said it has received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers. The…
5 years ago proactiveinvestors.com
Canntab Therapeutics reaches agreement with 36Eight Technologies to provide effective medical solutions for patients
Canntab Therapeutics Limited announced that it has reached an agreement with 36Eight Technologies Inc — a bioinformatics pharmacological healthcare data and technology company — to help the cannabis…
5 years ago prnewswire.com
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.
TORONTO, Oct. 18, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in…
5 years ago proactiveinvestors.com
Dow pulls to above the flatline after morning struggles as traders digest jobs data
12:30pm: Nasdaq finds little upward momentum The Dow clawed its way out of an early deficit to 15 points higher at midday at 34,615. The Nasdaq was down 117 points, 0.9%, at 13,641, and the S&P 500…
5 years ago proactiveinvestors.com
Canntab Therapeutics brings in C$1,259,250 gross from early exercise of warrants
Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the biopharma focused on hard pill cannabis formulations, said it had received C$1,259,250 gross from the early exercise of warrants.…
5 years ago prnewswire.com
Canntab Announces the Early Exercise of $1,259,250 Warrants
TORONTO, June 3, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in…
5 years ago proactiveinvestors.com
Canntab Therapeutics receives export license from Health Canada
Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1) said it has been granted an export license by Health Canada. The maker of hard pill cannabinoid formulations said it can now fulfill…
5 years ago prnewswire.com
Canntab Receives Export License Approval from Health Canada
TORONTO, March 30, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday